In a regulatory filing, Oscar Health (OSCR) disclosed that its CEO bought 1.0M shares of common stock on April 6th in a total transaction size of $11.9M. Shares are up 6% afterhours at $13.75.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR:
- Oscar Health Reaffirms 2026 Outlook at Investor Conference
- Oscar Health call volume above normal and directionally bullish
- Oscar Health upgraded to Outperform from Market Perform at Raymond James
- Oscar Health price target lowered to $15 from $17 at UBS
- Oscar Health: Overly Optimistic Growth Assumptions and Rising Medical Cost Risks Drive Sell Rating